Beta-cyclodextrin remains the most widely produced and commercially used form, largely because of its favorable cavity size, relatively low production cost, and well-documented safety profile.

A new class of beta blockers designed to activate only when struck by specific wavelengths of light could allow doctors to ...

monday.com Ltd. (NASDAQ:MNDY) is one of the 11 best software application stocks to buy now. On March 11, monday.com Ltd. (NASDAQ:MNDY) unveiled new infrastructure that allows AI agents to register and ...

Groundbreaking First-in-Human Study Demonstrates Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without ...

On March 17, Orlando Bravo, Founder and Managing Partner of private equity firm Thoma Bravo, spoke with CNBC about the impact ...

This healing and hydrating ingredient is rapidly emerging as a multi-tasking saviour for sensitive skin, writes Megan Fahy ...

ATLANTA, March 16, 2026 (GLOBE NEWSWIRE) -- bloomway.ai begins public beta testing today.Bloomway AI based in Atlanta, Georgia, the company ...

In interviews with business leaders across industries, AI Monster ( founders repeatedly heard the same frustrations from their peers:-- "AI courses are sort of us ...

Fed up with the random nature of generative AI? Adobe Firefly’s new Custom Models seek to change that by learning your own ...

Endogenex today announced new findings supporting its technology for improving outcomes in individuals with type 2 diabetes.

Digi International (NASDAQ:DGII) reflects steady performance alongside strong quarterly updates and valuation positioning. Institutional participation remains elevated, reinforcing the company’s role ...

In a 14-month follow-up, Sana Biotechnology has found that its investigational allogeneic cell therapy continued to produce insulin in one patient with Type 1 diabetes, with no safety concerns ...